Recent progress in prion and prion-like protein aggregation

被引:5
|
作者
Yi, Chuan-Wei [1 ]
Xu, Wen-Chang [1 ]
Chen, Jie [1 ]
Liang, Yi [1 ]
机构
[1] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China
基金
中国国家自然科学基金;
关键词
prion protein; prion-like protein; protein misfolding; physiological environment; macromolecular crowding; AMYOTROPHIC-LATERAL-SCLEROSIS; MISFOLDING CYCLIC AMPLIFICATION; MUTANT SUPEROXIDE-DISMUTASE; SPONGIFORM ENCEPHALOPATHY; SCRAPIE PRION; ALZHEIMERS-DISEASE; TAU AGGREGATION; WILD-TYPE; TRANSMISSION; PROPAGATION;
D O I
10.1093/abbs/gmt052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion diseases and prion-like protein misfolding diseases involve the accumulation of abnormally aggregated forms of the normal host proteins, such as prion protein and Tau protein. These proteins are special because of their self-duplicating and transmissible characteristics. Such abnormally aggregated proteins mainly formed in neurons, cause the neurons dysfunction, and finally lead to invariably fatal neurodegenerative diseases. Prion diseases appear not only in animals, such as bovine spongiform encephalopathy in cattle and scrapie in sheep, but also in humans, such as CreutzfeldtJacob disease, and even the same prion or prion-like proteins can have many different phenotypes. A lot of biological evidence has suggested that the molecular basis for different strains of prions could be hidden in protein conformations, and the misfolded proteins with conformations different from the normal proteins have been proved to be the main cause for protein aggregation. Crowded physiological environments can be imitated in vitro to study how the misfolding of these proteins leads to the diseases in vivo. In this review, we provide an overview of the existing structural information for prion and prion-like proteins, and discuss the post-translational modifications of prion proteins and the difference between prion and other infectious pathogens. We also discuss what makes a misfolded protein become an infectious agent, and show some examples of prion-like protein aggregation, such as Tau protein aggregation and superoxide dismutase 1 aggregation, as well as some cases of prion-like protein aggregation in crowded physiological environments.
引用
收藏
页码:520 / 526
页数:7
相关论文
共 50 条
  • [41] Prion-like Spreading in Tauopathies
    Ayers, Jacob I.
    Giasson, Benoit I.
    Borchelt, David R.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (04) : 337 - 346
  • [42] Prion-like properties for tau
    Tolnay, M.
    BRAIN PATHOLOGY, 2014, 24 : 13 - 13
  • [44] Prion-like transmission of protein aggregates in neurodegenerative diseases
    Patrik Brundin
    Ronald Melki
    Ron Kopito
    Nature Reviews Molecular Cell Biology, 2010, 11 : 301 - 307
  • [45] Are synucleinopathies prion-like disorders?
    Angot, Elodie
    Steiner, Jennifer A.
    Hansen, Christian
    Li, Jia-Yi
    Brundin, Patrik
    LANCET NEUROLOGY, 2010, 9 (11): : 1128 - 1138
  • [46] Prion-Like Protein Aggregates and Type 2 Diabetes
    Mukherjee, Abhisek
    Soto, Claudio
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (05):
  • [47] The propagation of prion-like protein inclusions in neurodegenerative diseases
    Goedert, Michel
    Clavaguera, Florence
    Tolnay, Markus
    TRENDS IN NEUROSCIENCES, 2010, 33 (07) : 317 - 325
  • [48] Targeting prion-like protein spreading in neurodegenerative diseases
    Zhaohui Zhang
    Shuke Nie
    Liam Chen
    Neural Regeneration Research, 2018, 13 (11) : 1875 - 1878
  • [49] Prion-like transmission of protein aggregates in neurodegenerative diseases
    Brundin, Patrik
    Melki, Ronald
    Kopito, Ron
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (04) : 301 - 307
  • [50] TIA-1 Is a Functional Prion-Like Protein
    Rayman, Joseph B.
    Kandel, Eric R.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2017, 9 (05):